SFX by Ex Libris Inc.

Title:	Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Source:	Nature [0028-0836] Lee, D I yr:2015

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Muoio, Deborah M. "Diabetes: The good in fat." Nature advance online publication.7529 (2014): 49-50.
description	2.	Schuetze, Katherine B. "Targeting Cardiac Fibroblasts to Treat Fibrosis of the Heart: Focus on HDACs." Journal of molecular and cellular cardiology 70 (2014): 100-107.
description	3.	Noma, T. "β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection." The Journal of clinical investigation 117.9 (2007): 2445-2458.
description	4.	Paterniti, I. "PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury." PLoS ONE 6.1 (2011): 1-15.
description	5.	Herzog, Charles A A. "Is there something special about ischemic heart disease in patients undergoing dialysis?" The American heart journal 147.6 (2004): 942-4.
description	6.	Torpy, M. JAMA 301.15 (2009): 1620-1620.
description	7.	Nath, D. "Diabetes." Nature 414.6865 (2001): 781-781.
description	8.	"Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study." Kidney international supplements 65.6: 2380-2389.
description	9.	Bobin, P. "Calmodulin kinase II inhibition limits the pro-arrhythmic Ca2+ waves induced by cAMP-phosphodiesterase inhibitors." Cardiovascular research 110.1 (2016): 151-161.
description	10.	DEMARIA, M. "An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA." Developmental cell 31.6 (2014): 722-33.
description	11.	Glukhov, Alexey V. "Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex." European heart journal (2013).
description	12.	Neufer, Deborah D. "Lipid-induced mitochondrial stress and insulin action in muscle." Cell metabolism 15.5 (2012): 595-605.
description	13.	McKinsey, Timothy A. "Therapeutic Potential for HDAC Inhibitors in the Heart." Annual Review of Pharmacology and Toxicology 52.1 (2011): 303-319.
description	14.	Saczewski, J. "Synthesis of aza-aromatic hydroxylamine-O-sulfonates and their application to tandem nucleophilic addition-electrophilic 5-endo-trig cyclization." Tetrahedron 67.20 (2011): 3612-3618.
description	15.	Dulin, Jennifer N. "Spinal cord injury causes sustained disruption of the blood-testis barrier in the rat." PloS one 6.1 (2011).
description	16.	Saito, K. "An enzymatic photometric assay for 2-deoxyglucose uptake in insulin-responsive tissues and 3T3-L1 adipocytes." Analytical biochemistry 412.1 (2011): 9-17.
description	17.	Cuffaro, G. "Carbs & Cals: A visual guide to carbohydrate and calorie counting for people with diabetes." Journal of human nutrition and dietetics 23.6 (2010): 620-620.
description	18.	Lynch, M. "RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta(2)-adrenergic receptor to activation of ERK in HEK293B2 cells." The Journal of biological chemistry 280.39 (2005): 33178-33189.
description	19.	Foley, Robert N N. "Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure." Seminars in dialysis 16.2 (2003): 111-7.
description	20.	Xiao, Rui-Ping P. "Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts." Circulation 108.13 (2003): 1633-9.